BIX02188
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


BIX02188
Description:
BIX02188 is a potent MEK5-selective inhibitor with an IC50 of 4.3 nM. BIX02188 inhibits ERK5 catalytic activity, with an IC50 of 810 nM.UNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
ERK; MEKType:
Reference compoundRelated Pathways:
MAPK/ERK Pathway; Stem Cell/WntApplications:
Cancer-Kinase/proteaseField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/BIX02188.htmlConcentration:
10mMPurity:
99.85Solubility:
DMSO : ≥ 45 mg/mLSmiles:
O=C (N) C1=CC (NC2=O) =C (/C2=C (C3=CC=CC=C3) /NC4=CC=CC (CN (C) C) =C4) C=C1Molecular Formula:
C25H24N4O2Molecular Weight:
412.49Precautions:
H302, H315, H319, H335References & Citations:
[1]Li L, et al. Fluid shear stress inhibits TNF-mediated JNK activation via MEK5-BMK1 in endothelial cells. Biochem Biophys Res Commun. 2008 May 23;370 (1) :159-63.|[2]Tatake RJ, et al. Identification of pharmacological inhibitors of the MEK5/ERK5 pathway. Biochem Biophys Res Commun. 2008 Dec 5;377 (1) :120-5.|[3]Badshah II, et al. Erk5 is a mediator to TGFβ1-induced loss of phenotype and function in human podocytes. Front Pharmacol. 2014 Apr 21;5:71.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
ERK5; MEK5CAS Number:
334949-59-6
